MorphoSys AG · Martinsried/Planegg Germany (German: MOR)
Key MorphoSys AG Financials
| Company Type | Public -(German: MOR) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $115.3 |
| 2010 Employees | 435 |
MorphoSys AG Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 115.3 | 116.1 | 101.0 |
| Cost of Goods Sold | 9.7 | 9.7 | 10.1 |
| Gross Profit | 105.7 | 106.5 | 90.9 |
| Gross Profit Margin | 91.6% | 91.7% | 90% |
| SG&A Expense | 30.8 | 34.3 | 28.9 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | 13.1 | 16.3 | 23.1 |
| Operating Margin | 11.3% | 14.1% | 22.9% |
| Nonoperating Income | (1.0) | 2.4 | 0.1 |
| Nonoperating Expenses | 5.4 | (0.0) | 2.1 |
| Income Before Taxes | 17.5 | 18.7 | 25.4 |
| Income Taxes | 5.3 | 5.8 | 6.8 |
| Net Income After Taxes | 12.2 | 12.8 | 18.5 |
| Continuing Operations | 12.2 | 12.8 | 18.5 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 12.2 | 12.8 | 18.5 |
| Total Net Income | 12.2 | 12.8 | 18.5 |
| Net Profit Margin | 10.6% | 11.1% | 18.4% |
| Diluted EPS from Total Net Income | 0.53 | 0.57 | 0.83 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
MorphoSys AG Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 58.5 | 59.1 | 56.5 |
| Net Receivables | -- | -- | -- |
| Inventories | 5.5 | 5.7 | 5.0 |
| Other Current Assets | 111.7 | 158.1 | 150.1 |
| Total Current Assets | 175.6 | 223.0 | 211.6 |
| Net Fixed Assets | 8.2 | 7.2 | 5.6 |
| Other Noncurrent Assets | 97.9 | 65.2 | 69.4 |
| Total Assets | 281.7 | 295.4 | 286.5 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 20.7 | 20.2 | 16.4 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 7.6 | 14.5 | 22.3 |
| Total Current Liabilities | 28.3 | 34.8 | 38.6 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 7.0 | 11.3 | 19.6 |
| Total Liabilities | 35.3 | 46.1 | 58.2 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 246.4 | 249.3 | 228.3 |
| Total Equity | 246.4 | 249.3 | 228.3 |
| Shares Outstanding (thou.) | 22,890.3 | 22,660.6 | 22,398.9 |
All amounts in millions of US Dollars except per share amounts.
MorphoSys AG Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 3 | (1) | 40 |
| Net Investing Cash Flow | (2.6) | 0.9 | (55.4) |
| Net Financing Cash Flow | 3.0 | 2.0 | 3.5 |
| Net Change in Cash | 3.8 | 1.6 | (11.7) |
| Depreciation & Amortization | |||
| Capital Expenditures | (18.3) | (5.5) | (5.5) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.